Federal officials are warning of a possible ADHD drug shortage after a subscription-based telehealth company was busted for fraud.
The Justice Department said the company sent 40 million pills to people who lacked legitimate prescriptions, and generated more than $100 million in revenue. The DOJ said He and Brody conspired to provide easy access to Adderall and other stimulants through a monthly subscription fee with Done.The Centers for Disease Control and Prevention said patients who rely on ADHD medication through Done or similar subscription-based telehealth platforms may experience a disruption to their treatment or access to care.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: